BaHoF5 nanoprobes as high-performance contrast agents for multi-modal CT imaging of ischemic stroke

Biomaterials
Jing WangZhenwei Yao

Abstract

CT angiography (CTA) and CT perfusion (CTP) imaging can play important roles in the workup of acute ischemic stroke. However, these techniques are hindered by the large amounts of contrast agents (CAs) required, high doses of X-ray radiation exposure, and nephrotoxicity of the clinical used iodinated CAs. To address these problems, we synthesized and validated a novel class of CT CAs, PEGylated BaHoF5 nanoparticles (NPs), for CTA and CTP imaging, which can greatly enhance the diagnostic sensitivity and accuracy of ischemic stroke. These agents have unique advantages over conventional iodinated CT agents, including much lower dosage required, major metabolism through liver and better imaging efficiency at different voltages. Once translated, these PEGylated BaHoF5 NPs can replace iodine-based CAs for diagnostic contrast-enhanced imaging of patients with kidney/heart diseases and improve the overall diagnostic index with negligible side effects.

References

Dec 26, 2001·Chemical Reviews·S B Yu, A D Watson
Feb 25, 2003·European Journal of Radiology·Matthias König
Sep 2, 2005·Nature·Xun WangYadong Li
Oct 2, 2007·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Margaret Kelly-HayesPhilip A Wolf
Apr 16, 2009·Nano Letters·Rachela PopovtzerRaoul Kopelman
Apr 28, 2012·Biomaterials·Huaiyong XingJianlin Shi
Nov 30, 2013·Neurologic Clinics·May Nour, David S Liebeskind
Feb 8, 2014·Stroke; a Journal of Cerebral Circulation·Cheryl BushnellUNKNOWN Council for High Blood Pressure Research
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Jun 12, 2014·Stroke; a Journal of Cerebral Circulation·Kambiz NaelChelsea S Kidwell
Sep 26, 2014·Neuroradiology·Amanda MurphyRichard I Aviv

❮ Previous
Next ❯

Citations

Sep 14, 2016·Advanced Drug Delivery Reviews·Benjamin M YehPeter J Bonitatibus
Mar 5, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Christos TapeinosGianni Ciofani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.